Alteraciones motoras gástricas

  1. S. de la Riva 1
  2. M. Alonso Sierra 1
  3. M. Muñoz-Navas 1
  1. 1 Clínica Universitaria de Navarra
    info

    Clínica Universitaria de Navarra

    Pamplona, España

    ROR https://ror.org/03phm3r45

Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2016

Título del ejemplar: Enfermedades del aparato digestivo (II): Patología gastroduodenal (I)

Serie: 12

Número: 2

Páginas: 74-81

Tipo: Artículo

DOI: 10.1016/J.MED.2016.01.012 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

Introducción El estómago es el segmento del tracto gastrointestinal donde tienen inicio las principales funciones de secreción y digestión del tubo digestivo. Fisiopatología Sin embargo, la función gástrica más crítica e importante en la fisiología digestiva está dada por su actividad motora, que permite el almacenaje, el inicio del proceso de trituración, digestión y vaciamiento/progresión del alimento al resto de tracto digestivo. Alteraciones en este complejo proceso de coordinación pueden conducir a modificaciones en el vaciamiento gástrico. Gastroparesia Aunque existen patologías en las que tiene lugar una aceleración del vaciamiento gástrico, la disfunción motora por retardo es la que predomina y, por este motivo, es la que ocupa gran parte de esta revisión.

Referencias bibliográficas

  • Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L; American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18-37.
  • Koch KL. Gastric neuromuscular function and neuromuscular disorders. En: Feldman M, Friedman LS, Brandt LJ, editors. Sleissenger and Fordtran’s. Gastrointetsinal and liver disease. Vol 2. 10ª ed. Estados Uni-dos: Elsevier; 2016. p. 829-32.
  • Vittal H, Farrugia G, Gómez G, Pasricha PJ. Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies.Nat Clin Pract Gastroenterol Hepatol. 2007;4(6):336-46.
  • Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001;49(3):395-401.
  • Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care. 1999;22(3):503-7.
  • Jung HK. The incidence, prevalence, and survival of gastroparesis in olmsted county, Minnesota, 1996-2006 (gastroenterology 2009; 136:1225-1233). J Neurogastroenterol Motil. 2010;16(1):99-100.
  • Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43(11):2398-404.
  • Parkman HP, Schwartz SS. Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch Intern Med. 1987;147(8):1477-80.
  • Camilleri M. Management of patients with chronic abdominal pain in clinical practice. Neurogastroenterol Motil. 2006;18(7):499-506.
  • Hoogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol. 1999;94(4):1029-33.
  • Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis clinical characteristics and long-term outcomes. Am J Gastroenterol. 1997;92(9):1501-4.
  • Forster J, Damjanov I, Lin Z, Sarosiek I, Wetzel P, McCallum RW. Abs-ence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg. 2005;9(1):102-8.
  • Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology. 1995;109(3):755-65.
  • Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161(16): 1989-96.
  • Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001; 24(7):1264-9.
  • Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, et al; National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium.Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepa-tol. 2011;9(12):1056-64.
  • Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am. 1992;72(2):445-65.
  • Fich A, Neri M, Camilleri M, Kelly KA, Phillips SF. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol. 1990;12(5):505-12.
  • Bredenoord AJ, Chial HJ, Camilleri M, Mullan BP, Murray JA. Gastric accommodation and emptying in evaluation of patients with upper gas-trointestinal symptoms. Clin Gastroenterol Hepatol. 2003;1(4):264-72.
  • Horowitz M, Cook DJ, Collins PJ, Harding PE, Hooper MJ, Walsh JF, et al. Measurement of gastric emptying after gastric bypass surgery using radionuclides. Br J Surg. 1982;69(11):655-7.
  • Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis clinical characteristics and long-term outcomes. Am J Gastroenterol. 1997;92(9):1501-4.
  • Lobrano A, Blanchard K, Abell TL, Minocha A, Boone W, Wyatt-Ash-mead J, et al. Postinfectious gastroparesis related to autonomic failure: a case report. Neurogastroenterol Motil. 2006;18(2):162-7.
  • Parkman HP. Scintigraphy for evaluation of patients for GI motility disorders--the referring physician’s perspective. Semin Nucl Med. 2012; 2(2):76-8.
  • Guo JP, Maurer AH, Fisher RS, Parkman HP. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastropa-resis. Dig Dis Sci. 2001;46(1):24-9.
  • Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, et al; American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103(3):753-63.
  • Tougas G, Chen Y, Coates G, Paterson W, Dallaire C, Paré P, et al. Stan-dardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting. Am J Gastroenterol. 2000; 95(1):78-86.
  • Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110(4):1036-42.
  • Bromer MQ, Kantor SB, Wagner DA, Knight LC, Maurer AH, Parkman HP. Simultaneous measurement of gastric emptying with a simple muffin meal using [13C] octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms. Dig Dis Sci. 2002;47(7):1657-63.
  • Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson JZ, et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008;6(6):635-43.
  • Rao SS, Camilleri M, Hasler WL, Maurer AH, Parkman HP, Saad R, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011;23(1):8-23.
  • Tang DM, Friedenberg FK. Gastroparesis: approach, diagnostic evaluation, and management. Dis Mon. 2011;57(2):74-101.
  • Kuo B, McCallum RW, Koch KL, Sitrin MD, Wo J M, Chey WD, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008;27(2):186-96.
  • Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measure-ment of gastrointestinal motility in the GI laboratory. Gastroenterology. 1998;115(3):747-62.
  • Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000;95(12):3374-82.
  • Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis.Clin Gastroenterol Hepatol. 2011;9(1):5-12.
  • Patterson D, Abell T, Rothstein R, Koch K, Barnett J. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol. 1999;94(5):1230-4.
  • PeetersTL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology. 1993;105(6):1886-99.
  • DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gas-troenterol. 1999;94(6):1434-42.
  • Hasler WL.Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol. 2011;8(8):438-53.
Fuente de los datos: Dialnet